Standout Papers

The diagnosis of dementia due to Alzheimer's disease: Recommendation... 2005 2026 2012 2019 13.3k
  1. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011)
    Guy M. McKhann, David S. Knopman et al. Alzheimer s & Dementia
  2. Consistent resting-state networks across healthy subjects (2006)
    Jessica S. Damoiseaux, Serge A.R.B. Rombouts et al. Proceedings of the National Academy of Sciences
  3. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (2007)
    Bruno Dubois, Howard Feldman et al. The Lancet Neurology
  4. Alzheimer's disease (2016)
    Philip Scheltens, Kaj Blennow et al. The Lancet
  5. Risk of dementia in diabetes mellitus: a systematic review (2005)
    Geert Jan Biessels, Salka S. Staekenborg et al. The Lancet Neurology
  6. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT (2001)
    Lars‐Olof Wahlund, Frederik Barkhof et al. Stroke
  7. The clinical use of structural MRI in Alzheimer disease (2010)
    Giovanni B. Frisoni, Nick C. Fox et al. Nature Reviews Neurology
  8. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. (1992)
    Philip Scheltens, Didier Leys et al. Journal of Neurology Neurosurgery & Psychiatry
  9. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016)
    Clifford R. Jack, David A. Bennett et al. Neurology
  10. Reduced resting-state brain activity in the “default network” in normal aging (2007)
    Jessica S. Damoiseaux, Christian F. Beckmann et al. Cerebral Cortex
  11. Small-World Networks and Functional Connectivity in Alzheimer's Disease (2006)
    Cornelis J. Stam, B.F. Jones et al. Cerebral Cortex
  12. White matter hyperintensities, cognitive impairment and dementia: an update (2015)
    Niels D. Prins, Philip Scheltens Nature Reviews Neurology
  13. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging (1993)
    Philip Scheltens, Frederik Barkhof et al. Journal of the Neurological Sciences
  14. Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease (2008)
    Cornelis J. Stam, Willem de Haan et al. Brain
  15. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: An fMRI study (2005)
    Serge A.R.B. Rombouts, Frederik Barkhof et al. Human Brain Mapping
  16. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup (2024)
    Clifford R. Jack, J. Scott Andrews et al. Alzheimer s & Dementia
  17. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations (2010)
    Alida A. Gouw, Alexandra Seewann et al. Journal of Neurology Neurosurgery & Psychiatry
  18. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup (2011)
    Reisa A. Sperling, Clifford R. Jack et al. Alzheimer s & Dementia
  19. Diagnostic Criteria for Vascular Cognitive Disorders (2014)
    Perminder S. Sachdev, Raj N. Kalaria et al. Alzheimer Disease & Associated Disorders
  20. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis (1998)
    M.A.A. van Walderveen, Wouter Kamphorst et al. Neurology
  21. The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials (2015)
    Colin Groot, Astrid M. Hooghiemstra et al. Ageing Research Reviews
  22. A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease (2017)
    Susanne Ostrowitzki, Robert Lasser et al. Alzheimer s Research & Therapy
  23. Vascular cognitive impairment (2018)
    Wiesje M. van der Flier, Ingmar Skoog et al. Nature Reviews Disease Primers
  24. Current state of Alzheimer’s fluid biomarkers (2018)
    José Luís Molinuevo, Scott Ayton et al. Acta Neuropathologica
  25. Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges (2015)
    Bruno Dubois, Alessandro Padovani et al. Journal of Alzheimer s Disease
  26. On the path to 2025: understanding the Alzheimer’s disease continuum (2017)
    Paul Aisen, Jeffrey L. Cummings et al. Alzheimer s Research & Therapy
  27. Drug development in Alzheimer’s disease: the path to 2025 (2016)
    Jeffrey L. Cummings, Paul Aisen et al. Alzheimer s Research & Therapy
  28. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised (2021)
    Giovanni B. Frisoni, Daniele Altomare et al. Nature reviews. Neuroscience
  29. Amsterdam Dementia Cohort: Performing Research to Optimize Care (2018)
    Wiesje M. van der Flier, Philip Scheltens Journal of Alzheimer s Disease
  30. The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease (2020)
    Martí Colom‐Cadena, Tara L. Spires‐Jones et al. Alzheimer s Research & Therapy
  31. evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease (2025)
    Jeffrey L. Cummings, Alireza Atri et al. Alzheimer s Research & Therapy

Immediate Impact

4 by Nobel laureates 16 from Science/Nature 213 standout
Sub-graph 1 of 15

Citing Papers

Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
2024 Standout
Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
2023 Standout
102 intermediate papers

Works of Philip Scheltens being referenced

The “rights” of precision drug development for Alzheimer’s disease
2019
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
2011 Standout
and 90 more

Author Peers

Author Last Decade Papers Cites
Philip Scheltens 42680 35634 29096 1.2k 97.2k
David S. Knopman 46210 39897 22491 986 90.7k
Clifford R. Jack 52132 44990 29145 1.1k 101.3k
Ronald C. Petersen 59507 50178 28644 1.1k 112.7k
John C. Morris 46867 43206 24123 986 112.4k
Jeffrey L. Cummings 43937 30007 21266 946 99.9k
Michael W. Weiner 29962 27237 19528 876 69.0k
Bruce L. Miller 31246 28417 28222 1.1k 87.9k
Frederik Barkhof 16795 12525 17276 1.4k 86.4k
William J. Jagust 31635 27333 19881 475 59.4k
Steven T. DeKosky 28721 24817 11523 539 62.2k

All Works

Loading papers...

Rankless by CCL
2026